Maternal prenatal urinary bisphenol A level and child cardio-metabolic risk factors: A prospective cohort study

Fengxiu Ouyang1, Guang-Hui Zhang2, Kun Du2

  • 1Ministry of Education and Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Insights

Maternal prenatal exposure to Bisphenol A (BPA) may increase children's blood pressure and glucose levels. These effects were observed in a sex-specific manner, with higher risks noted in girls for blood pressure and in boys for glucose.

Area of Science:

  • Environmental Health
  • Endocrinology
  • Pediatrics

Background:

  • Exposure to endocrine disrupting chemicals during early development can lead to long-term health issues.
  • Bisphenol A (BPA) is an endocrine disrupting chemical with widespread human exposure.
  • The first 1000 days of life represent a critical window for development and susceptibility to environmental exposures.

Purpose of the Study:

  • To investigate the association between maternal prenatal Bisphenol A (BPA) exposure and cardio-metabolic risk factors in children at age 2.
  • To explore potential sex-specific effects of prenatal BPA exposure on child health outcomes.

Main Methods:

  • Prospective cohort study of 218 pregnant women in Shanghai, China (2012-2013).
  • Measurement of urinary BPA concentrations in mothers during pregnancy and in children at age 2.
  • Assessment of child cardio-metabolic risk factors including adiposity, plasma glucose, insulin, lipids, systolic blood pressure (SBP), and diastolic blood pressure (DBP).
  • Linear regression analysis adjusted for relevant covariates to examine associations between prenatal BPA and child outcomes.

Main Results:

  • High prenatal BPA exposure was associated with significantly higher SBP (7.0 mmHg) and DBP (4.4 mmHg) in girls compared to low exposure, but not in boys.
  • Medium prenatal BPA exposure was linked to higher plasma glucose (0.36 mmol/L) in boys.
  • No significant associations were found between prenatal BPA and child BMI, skinfold thickness, serum lipids, or insulin in either sex.
  • Concurrent BPA exposure in children at age 2 showed no association with cardio-metabolic risk factors.

Conclusions:

  • Prenatal BPA exposure may be associated with increased blood pressure in girls and elevated plasma glucose in boys at age 2.
  • These findings suggest sex-specific effects of BPA on early-life cardio-metabolic development.
  • Further research in independent cohorts is warranted to confirm these sex-specific associations.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.8K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
121
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
771